Intelligent surgical targeting

January 13, 2021

Press release

FluoGuide gets green light to proceed to third dose level with FG001 in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 13 January 2021 – FluoGuide A/S (“FluoGuide” or the... [Read more]

December 29, 2020

Press release

Board member of FluoGuide sells some of his shares to pay capital gain tax on his shareholding

Copenhagen, Denmark, 29 December 2020 – FluoGuide A/S (“FluoGuide” or “the... [Read more]

December 17, 2020

Press release

FluoGuide gets green light to proceed to second dose level with FG001 in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 17 December 2020 – FluoGuide A/S (“FluoGuide” or the... [Read more]

November 30, 2020

Press release

FluoGuide obtains patent protection for FG001 in Australia

Copenhagen, Denmark, 30 November 2020 – FluoGuide A/S (“FluoGuide” or the... [Read more]